Bayer CropScience Ltd logo

Bayer CropScience Ltd

BAYERCROP NSE

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

AI Verdict: HOLD Confidence: 5%

Bayer CropScience is a high-quality, debt-free compounder with 24% ROE and 74.3% dividend payout, but its premium valuation at 27.8x PE is hard to justify given tepid 3-5% sales growth and a stock that has delivered -23% returns over the past year. Wait for a better entry point or clearer growth catalysts.

Key Fundamentals

SmallcapPesticides & AgrochemicalsChemicals
Market Cap
₹18,966 Cr
Volatility
Moderate
P/E Ratio
27.3
EBITDA
₹809 Cr
Return on Equity
25.99%
Debt to Equity
0.03
Book Value
₹659.9
EPS
₹148.24
52W High
₹6,511
52W Low
₹4,150

Technical Indicators

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 74.3%
  • Company's working capital requirements have reduced from 75.2 days to 59.8 days

Weaknesses

1
  • The company has delivered a poor sales growth of 5.90% over past five years.

Growth Rate

Revenue Growth
7.89% ↗
Net Income Growth
-23.30% ↘
Cash Flow Change
-72.47% ↘
ROE
-23.32% ↘
ROCE
-25.19% ↘
EBITDA Margin (Avg.)
-27.51% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 3d ago
HOLD
Risk medium

Bayer CropScience is a high-quality, debt-free compounder with 24% ROE and 74.3% dividend payout, but its premium valuation at 27.8x PE is hard to justify given tepid 3-5% sales growth and a stock that has delivered -23% returns over the past year. Wait for a better entry point or clearer growth catalysts.

Bull Case 7
  • Consistently high return on equity at 24% last year and 23-24% average over 3-5 years, indicating superior capital efficiency
  • Virtually debt-free balance sheet provides financial resilience and flexibility for future investments or acquisitions
  • Healthy dividend payout ratio of 74.3% with 2.11% dividend yield offers steady income in a volatile market
  • Working capital efficiency improved significantly from 75.2 days to 59.8 days, freeing up cash for operations
  • TTM profit growth of 21% shows meaningful margin expansion and operational leverage kicking in
  • Backed by Bayer AG, a global agrochemical leader, providing access to proprietary molecules, R&D pipeline, and technology transfer
  • Long-term compounded profit growth of 8% over 10 years demonstrates consistent earnings trajectory despite cyclical headwinds
Bear Case 7
  • Poor revenue growth of just 3% CAGR over 3 years and 6% over 5 years signals limited topline momentum in a growing agri market
  • Stock has delivered -23% returns over 1 year and 0% over 3 years, massively underperforming broader indices
  • PE ratio of 27.8x is elevated for a company growing sales at only 4% TTM, implying overvaluation risk
  • Price-to-book of 6.47x is steep and leaves little margin of safety for new investors at current levels
  • 10-year stock CAGR of just 1% shows the market has not rewarded long-term holders despite decent fundamentals
  • 5-year stock CAGR of -5% indicates persistent de-rating, suggesting structural concerns about growth runway
  • Analyst consensus is split 50-50 between buy and hold with zero strong conviction, reflecting uncertainty about near-term catalysts

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 14h ago
Positives 3
  • FY26 profit surges 21.4% May 26

    Net profit rose 21.4% to ₹6,892 million for FY26, with revenue from operations up 3.7% to ₹56,750 million. EBITDA margin improved to 18.4% in Q4 vs 16.3% YoY.

  • Q4 profit up 13%, ₹60 dividend May 26

    Q4 FY26 net profit rose 13.1% YoY to ₹162 crore with EBITDA of ₹202.9 crore. Board recommended final dividend of ₹60 per share for FY26.

  • Strong cost and cash discipline May 26

    Management highlighted disciplined cost and cash flow management keeping the balance sheet strong. PBT for FY26 stood at ₹854.9 crore vs ₹707.4 crore last year, a 20.8% jump.

Neutral 2
  • Trading window closed from Jul 1 Jun 18

    Bayer CropScience shuts trading window from July 1, 2026 until Q1 FY27 results are declared, per SEBI insider trading regulations.

  • ₹67.65 cr block trade on NSE Jun 9

    Approximately 1.58 lakh shares changed hands at ₹4,271 per share in an institutional block deal worth ₹67.65 crore on NSE.

TL;DR: Bayer CropScience delivered a strong FY26 with 21% profit growth, margin expansion, and a healthy ₹60 dividend, reflecting disciplined execution despite a softer corn season and Kharif disruptions. No material headwinds emerged in recent news flow. The institutional block trade and trading window closure are routine events. The trend is improving, with management signalling confidence in sustainable, quality-led growth ahead.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
982
1,740
1,617
955
792
1,631
1,738
1,057
1,046
1,915
1,553
1,106
1,101
Expenses
777
1,315
1,312
827
695
1,317
1,554
1,037
876
1,566
1,348
989
898
Operating Profit
206
425
305
128
97
314
184
20
171
348
205
117
203
OPM %
21%
24%
19%
13%
12%
19%
11%
2%
16%
18%
13%
11%
18%
Other Income
24
21
16
15
29
27
24
32
37
19
14
16
47
Interest
7
8
4
3
5
4
3
4
6
5
4
5
6
Depreciation
27
31
12
15
16
22
14
15
34
27
14
15
38
PBT
195
406
306
124
105
316
190
34
168
335
200
113
206
Tax %
19%
19%
27%
25%
9%
20%
28%
-2%
15%
17%
24%
15%
21%
Net Profit
158
328
223
93
96
254
136
34
143
279
153
96
162
EPS in Rs
35.27
73.09
49.6
20.72
21.36
56.56
30.33
7.61
31.89
62.01
33.98
21.29
36.07
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
3,660
2,769
2,803
2,710
3,167
3,609
4,261
4,734
5,140
5,106
5,473
5,675
Expenses
3,144
2,334
2,389
2,300
2,684
2,883
3,450
3,923
4,216
4,147
4,783
4,801
Operating Profit
516
435
414
410
483
726
812
812
924
959
691
874
OPM %
14%
16%
15%
15%
15%
20%
19%
17%
18%
19%
13%
15%
Other Income
88
82
70
39
51
-64
69
112
168
76
118
95
Interest
5
10
7
11
10
14
13
13
22
20
17
20
Depreciation
25
25
29
33
44
65
74
64
80
74
85
94
PBT
574
482
448
404
480
583
794
847
990
941
707
855
Tax %
33%
35%
35%
26%
30%
19%
38%
24%
23%
21%
20%
19%
Net Profit
383
315
291
300
337
474
493
645
758
740
568
689
EPS in Rs
105
89.13
82.31
87.41
98.18
106
110
144
169
165
126
153
Div. Payout %
20%
19%
21%
21%
18%
24%
105%
104%
77%
85%
99%
39%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
37
35
35
34
34
45
45
45
45
45
45
45
Reserves
1,996
1,804
2,021
1,744
2,205
2,528
2,505
2,479
2,667
2,804
2,806
2,921
Borrowings
0
0
0
0
0
2
26
86
74
47
105
82
Other Liabilities
740
597
769
756
1,310
1,262
1,663
1,742
1,893
1,701
2,290
2,652
Total Liabilities
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Fixed Assets
322
290
342
334
440
468
425
468
462
414
470
581
CWIP
1
17
24
36
47
56
76
98
109
119
119
5
Investments
29
68
50
0
0
41
52
38
41
54
35
57
Other Assets
2,422
2,062
2,410
2,164
3,062
3,270
3,686
3,749
4,066
4,010
4,622
5,056
Total Assets
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
200
206
157
121
433
666
687
216
609
952
262
1,078
Investing
485
16
-8
38
-113
-29
7
64
83
0
86
72
Financing
-42
-590
-73
-581
-158
-148
-556
-703
-613
-656
-619
-624
Net Cash Flow
644
-367
76
-421
162
489
138
-424
79
296
-272
527
Free Cash Flow
297
170
108
80
378
638
656
168
537
912
222
1,014
CFO/OP
76
86
74
53
132
110
105
59
92
113
61
142
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
57
53
72
89
81
73
65
77
69
69
63
72
Inventory Days
85
169
178
175
294
206
226
235
268
222
319
231
Days Payable
40
52
67
67
164
101
142
127
129
87
148
134
Cash Conversion Cycle
102
171
184
197
211
177
149
185
208
204
234
169
Working Capital Days
53
92
104
134
116
77
61
84
86
78
88
60
ROCE %
31%
25%
23%
22%
25%
30%
31%
31%
34%
34%
25%
29%

Shareholding Pattern

As of Mar 2026
Promoters 71.43%
DIIs 11.89%
Public 8.41%
Others 4.39%
FIIs 3.89%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
3.62%
3.63%
3.30%
3.42%
3.49%
3.64%
3.79%
3.84%
3.89%
DIIs
12.44%
11.30%
12.19%
12.49%
12.85%
13.01%
12.66%
12.79%
12.64%
13.01%
13.21%
12.68%
12.80%
12.47%
12.08%
11.70%
11.55%
11.38%
11.21%
11.46%
11.89%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
8.48%
8.43%
8.70%
8.48%
8.22%
8.01%
8.19%
8.05%
8.23%
8.00%
7.59%
7.84%
7.74%
7.96%
8.58%
8.76%
8.88%
8.93%
9.08%
8.78%
8.41%
Others
7.64%
8.83%
7.68%
7.60%
7.50%
7.55%
7.72%
7.72%
7.69%
7.56%
7.77%
8.05%
4.41%
4.51%
4.61%
4.68%
4.65%
4.62%
4.49%
4.50%
4.39%
No. of Shareholders
65,285
65,088
62,321
62,178
60,230
57,760
57,896
57,048
57,253
48,404
45,329
46,907
45,852
46,201
51,289
54,289
54,216
55,753
58,109
58,571
55,795

Documents

1
Concall - Aug 2017 Aug 2017
2
Concall - Jun 2018 Jun 2018
3
Concall - Nov 2018 Nov 2018
4
Concall - May 2019 May 2019
5
Concall - Nov 2019 Nov 2019

Frequently Asked Questions about Bayer CropScience Ltd

What does Bayer CropScience Ltd do?
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
Where is Bayer CropScience Ltd (BAYERCROP) listed?
Bayer CropScience Ltd is listed on the Indian stock exchanges. It is listed on NSE: BAYERCROP and BSE: 506285. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Bayer CropScience Ltd belong to?
Bayer CropScience Ltd operates in the Commodities sector within the Fertilizers & Agrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Bayer CropScience Ltd?
Bayer CropScience Ltd has a market capitalisation of approximately ₹18965.56 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Bayer CropScience Ltd?
The Price-to-Earnings (PE) ratio of Bayer CropScience Ltd is 27.30. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Bayer CropScience Ltd?
Over the past 52 weeks, Bayer CropScience Ltd has traded between a low of ₹4,150 and a high of ₹6,511. This range helps investors understand the stock's price volatility and recent trading levels.
Does Bayer CropScience Ltd pay dividends?
Yes, Bayer CropScience Ltd has a dividend yield of 2.14%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Bayer CropScience Ltd?
Bayer CropScience Ltd has a Return on Equity (ROE) of 25.99%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Bayer CropScience Ltd on Tapetide?
On Tapetide, you can view Bayer CropScience Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Website bayer.in
CEO Mr. Simon-Thorsten Wiebusch
Employees 1,169
Listed 2010-01-08
Face Value ₹ 10
Issued Size 5,01,07,246

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List